| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.057 | 0.7 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |